S. Daniels

403 total citations
25 papers, 306 citations indexed

About

S. Daniels is a scholar working on Pharmacology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S. Daniels has authored 25 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 7 papers in Surgery and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S. Daniels's work include Inflammatory mediators and NSAID effects (8 papers), Anesthesia and Pain Management (6 papers) and Pain Mechanisms and Treatments (4 papers). S. Daniels is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Anesthesia and Pain Management (6 papers) and Pain Mechanisms and Treatments (4 papers). S. Daniels collaborates with scholars based in United States and United Kingdom. S. Daniels's co-authors include Nelly Boehm, Adrian L. Harris, J Carmichael, William J. Ennis, R. Gary Sibbald, Donald R. Mehlisch, Richard C. Hubbard, Paul J. Desjardins, Thomas R. Kimball and Ralf Meyer and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Fertility and Sterility.

In The Last Decade

S. Daniels

25 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Daniels United States 9 145 134 57 52 49 25 306
G C Fenn United Kingdom 9 183 1.3× 199 1.5× 53 0.9× 44 0.8× 20 0.4× 14 437
P. L�kken Norway 8 198 1.4× 216 1.6× 139 2.4× 35 0.7× 16 0.3× 8 439
John Moodie New Zealand 11 255 1.8× 130 1.0× 161 2.8× 53 1.0× 39 0.8× 17 442
Erich Keller Germany 9 28 0.2× 51 0.4× 18 0.3× 12 0.2× 30 0.6× 18 302
Jessica Brown United States 6 178 1.2× 54 0.4× 49 0.9× 122 2.3× 15 0.3× 11 244
Simone Y. Loo Canada 7 42 0.3× 43 0.3× 29 0.5× 214 4.1× 58 1.2× 7 399
Mi Kyoung Lee South Korea 11 134 0.9× 57 0.4× 56 1.0× 19 0.4× 18 0.4× 43 300
S. Roth United States 6 132 0.9× 214 1.6× 180 3.2× 27 0.5× 122 2.5× 11 427
R. S. B. Ehsanullah United Kingdom 8 225 1.6× 224 1.7× 15 0.3× 51 1.0× 12 0.2× 14 411
Qianqian Zhu China 14 187 1.3× 29 0.2× 66 1.2× 133 2.6× 4 0.1× 42 463

Countries citing papers authored by S. Daniels

Since Specialization
Citations

This map shows the geographic impact of S. Daniels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Daniels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Daniels more than expected).

Fields of papers citing papers by S. Daniels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Daniels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Daniels. The network helps show where S. Daniels may publish in the future.

Co-authorship network of co-authors of S. Daniels

This figure shows the co-authorship network connecting the top 25 collaborators of S. Daniels. A scholar is included among the top collaborators of S. Daniels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Daniels. S. Daniels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meeves, Suzanne, et al.. (2015). (401) Analgesic effectiveness of a new, extended-release ibuprofen in postoperative dental pain. Journal of Pain. 16(4). S76–S76. 2 indexed citations
2.
Altman, Roy D., et al.. (2013). Lower-dose indomethacin submicron particle capsules provide effective acute pain relief: Phase 3 study results. Osteoarthritis and Cartilage. 21. S267–S268. 1 indexed citations
3.
Argoff, Charles E., et al.. (2013). Diclofenac submicron particle capsules demonstrate early and sustained acute pain relief in a phase 3 study in patients following bunionectomy surgery. Osteoarthritis and Cartilage. 21. S291–S291. 3 indexed citations
4.
Strand, Vibeke, Raúl Altman, S. Daniels, & Garen Manvelian. (2012). Safety and efficacy profile of nano-formulated, lower dose non-steroidal anti-inflammatory drugs. Osteoarthritis and Cartilage. 20. S284–S285. 1 indexed citations
5.
Oh, Charles, et al.. (2008). (229) Efficacy of tapentadol immediate release in patients with pain after bunionectomy. Journal of Pain. 9(4). 33–33. 4 indexed citations
6.
Daniels, S., P. Desjardins, Steve Bird, Steven S. Smugar, & Andrew M. Tershakovec. (2006). Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: Results of two randomized, double-blind, placebo-controlled, single-dose studies. Clinical Therapeutics. 28(7). 1022–1034. 8 indexed citations
7.
Hatsis, Panos, Adam Brockman, S. Daniels, et al.. (2006). Study of brain and whole blood PK/PD of bortezomib in rat models. Journal of Clinical Oncology. 24(18_suppl). 12036–12036. 5 indexed citations
8.
Mehlisch, Donald R., Paul J. Desjardins, S. Daniels, & Richard C. Hubbard. (2004). The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain. The Journal of the American Dental Association. 135(11). 1578–1590. 14 indexed citations
9.
Daniels, S., et al.. (2004). Perioperative pain: other. Journal of Pain. 5(3). S79–S79. 1 indexed citations
10.
Lin, E., Christopher H. Crane, Jeffrey S. Morris, et al.. (2004). Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, ameliorated capecitabine (X) hand & foot syndrome (HFS) & enhanced survival in metastatic colorectal cancer (MCRC). Journal of Clinical Oncology. 22(14_suppl). 3584–3584. 4 indexed citations
11.
Daniels, S.. (2002). Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. Obstetrics and Gynecology. 100(2). 350–358. 57 indexed citations
12.
Daniels, S.. (2002). Cardiovascular sequelae of childhood hypertension. American Journal of Hypertension. 15(2). S61–S63. 25 indexed citations
13.
Daniels, S., et al.. (2002). Evaluation of a new composite dressing for the management of chronic leg ulcer wounds. Journal of Wound Care. 11(8). 290–294. 18 indexed citations
15.
Torri, Sarah, Michael E. Kuss, Sheela Talwalker, S. Daniels, & Michael C. Snabes. (2001). The cyclooxygenase (COX)-2 specific inhibitor valdecoxib effectively treats primary dysmenorrhea.. Fertility and Sterility. 76(3). S95–S95. 3 indexed citations
16.
Daniels, S., et al.. (1999). Dose ranging trial of the effect of MK-966 in primary dysmenorrhea. Clinical Pharmacology & Therapeutics. 65(2). 118–118. 8 indexed citations
17.
Daniels, S., et al.. (1998). Gases in medicine : anaesthesia. 4 indexed citations
18.
Kimball, Thomas R., et al.. (1996). The role of automatic endocardial edge detection in the evaluation of left ventricular diastolic function in children. Journal of the American Society of Echocardiography. 9(1). 18–26. 14 indexed citations
19.
Carmichael, J, et al.. (1994). Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis. British Journal of Cancer. 70(6). 1161–1164. 34 indexed citations
20.
Daniels, S. & Nelly Boehm. (1991). Auscultated fetal heart rate accelerations *1An alternative to the nonstress test. Journal of Nurse-Midwifery. 36(2). 88–94. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026